ITGA6 and neoplasm: Our results further indicated that miR-143-3p inactivated the MAPK/ERK and PI3K/AKT/STAT3 pathways in GBC cells by directly targeting ITGA6, resulting in a decrease in PLGF and the development of GBC angiogenesis and tumour growth.